Metastatic Colorectal Cancers Completed Phase 3 Trials for Erlotinib (DB00530)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00598156Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- TarcevaTreatment